Earnings Call for Q3FY22 of Apollo Hospitals Enterprise
Conference Call with Apollo Hospitals Enterprise Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript.12-02-2022
Earnings Call for Q3FY22 of Apollo Hospitals Enterprise
Conference Call with Apollo Hospitals Enterprise Management and Analysts on Q3FY22 Performance and Outlook. Listen to the full earnings transcript.APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
As per annexure enclosedApollo Hospitals net profit jumps 82% to Rs 243 cr in December quarter
'The third quarter saw us continue on the path to recovery in line with the revival in the overall economy,' Apollo Hospitals Group Chairman Prathap C Reddy notedAPOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Financial Results For The Quarter And Nine Months Ended 31/12/2021
As per annexure enclosedAPOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
As per annexure enclosedAPOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Announcement under Regulation 30 (LODR)-Credit Rating
As per annexure enclosedAPOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Dear Sir, Sub: Intimation in terms of Regulation 39(3) of the SEBI (LODR) Regulations, 2015 (Regulations) regarding loss of share certificate. This is to inform you that the Company has received intimation from shareholders on January 29, 2022 regarding loss of share certificates. In accordance with Regulation 39(3) of the Regulations, the details of the said share certificates are as given below: Folio No. Name of the Shareholder(s) No of equity shares held Share Certificate No. Distinctive Nos. 7635 Revathy S Varadhan 200 357637 7167363 to 7167562 8522 Shantha Rajan V N Rajan 600 358524 7497985 to 7498584 This is for your information.APOLLO HOSPITALS ENTERPRISE LTD. - 508869 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
As per annexure enclosed